These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23530416

  • 21. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE, Morgan D, Felsing D, Kondabolu K, Rowland NE, Robertson KL, Sakhuja R, Booth RG.
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [Abstract] [Full Text] [Related]

  • 22. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):171-84. PubMed ID: 17074317
    [Abstract] [Full Text] [Related]

  • 23. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze.
    da Silva ES, Poltronieri SC, Nascimento JO, Zangrossi H, Viana MB.
    Behav Brain Res; 2011 Jan 20; 216(2):692-8. PubMed ID: 20883726
    [Abstract] [Full Text] [Related]

  • 24. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ, Mannoury la Cour C, Chanrion B, Dupuis DS, Di Cara B, Audinot V, Cussac D, Newman-Tancredi A, Kamal M, Boutin JA, Jockers R, Marin P, Bockaert J, Muller O, Dekeyne A, Lavielle G.
    J Pharmacol Exp Ther; 2012 Mar 20; 340(3):750-64. PubMed ID: 22178752
    [Abstract] [Full Text] [Related]

  • 25. Serotonin₂A/C receptors mediate the aggressive phenotype of TLX gene knockout mice.
    Juárez P, Valdovinos MG, May ME, Lloyd BP, Couppis MH, Kennedy CH.
    Behav Brain Res; 2013 Nov 01; 256():354-61. PubMed ID: 23933143
    [Abstract] [Full Text] [Related]

  • 26. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Fletcher PJ, Sinyard J, Higgins GA.
    Pharmacol Biochem Behav; 2010 Nov 01; 97(1):170-8. PubMed ID: 20624416
    [Abstract] [Full Text] [Related]

  • 27. Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
    Vicente MA, Zangrossi H.
    Int J Neuropsychopharmacol; 2012 Apr 01; 15(3):389-400. PubMed ID: 21733232
    [Abstract] [Full Text] [Related]

  • 28. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M.
    Gastroenterology; 2008 Jun 01; 134(7):2004-13. PubMed ID: 18439428
    [Abstract] [Full Text] [Related]

  • 29. Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function.
    Conlon K, Miner W, McCleary S, McMurray G.
    BJU Int; 2012 Jul 01; 110(2 Pt 2):E113-7. PubMed ID: 22192599
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.
    Fevig JM, Feng J, Rossi KA, Miller KJ, Wu G, Hung CP, Ung T, Malmstrom SE, Zhang G, Keim WJ, Cullen MJ, Rohrbach KW, Qu Q, Gan J, Pelleymounter MA, Robl JA.
    Bioorg Med Chem Lett; 2013 Jan 01; 23(1):330-5. PubMed ID: 23177783
    [Abstract] [Full Text] [Related]

  • 31. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.
    Eur J Pharmacol; 2005 Mar 21; 511(1):9-19. PubMed ID: 15777774
    [Abstract] [Full Text] [Related]

  • 32. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
    Hadamitzky M, Feja M, Becker T, Koch M.
    Behav Pharmacol; 2009 Sep 21; 20(5-6):415-23. PubMed ID: 19730369
    [Abstract] [Full Text] [Related]

  • 33. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA, Olabisi OA, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 21; 28(3):547-57. PubMed ID: 15093963
    [Abstract] [Full Text] [Related]

  • 34. 5-HT 2A receptor activation of the external urethral sphincter and 5-HT 2C receptor inhibition of micturition: a study based on pharmacokinetics in the anaesthetized female rat.
    Mbaki Y, Gardiner J, McMurray G, Ramage AG.
    Eur J Pharmacol; 2012 May 05; 682(1-3):142-52. PubMed ID: 22374259
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG, Fang L, Huang Y, Wilczynski A, Sivendran S.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):1-9. PubMed ID: 19397907
    [Abstract] [Full Text] [Related]

  • 37. [Effect of tropoxin on cerebrovascular effects of meta-chlorophenylpiperazine and serotonin].
    Gorbunov AA, Gan'shina TS, Mirzoian RS.
    Eksp Klin Farmakol; 2010 Sep 01; 73(9):13-6. PubMed ID: 21086646
    [Abstract] [Full Text] [Related]

  • 38. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
    Allerton CM, Andrews MD, Blagg J, Ellis D, Evrard E, Green MP, Liu KK, McMurray G, Ralph M, Sanderson V, Ward R, Watson L.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5791-5. PubMed ID: 19716297
    [Abstract] [Full Text] [Related]

  • 39. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D, Nunes-de-Souza RL, Canto-de-Souza A.
    Behav Brain Res; 2012 Nov 01; 235(1):42-7. PubMed ID: 22800924
    [Abstract] [Full Text] [Related]

  • 40. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V, Nunes-de-Souza RL, Rodgers RJ, Canto-de-Souza A.
    Behav Brain Res; 2008 Feb 11; 187(1):72-9. PubMed ID: 17935799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.